Today's Top Stories


Hot Topics


Comment & Analysis »

Pharma Technology Focus – Issue 60

In this issue: Solving US drug pricing issues by importing cheaper Canadian drugs, underexplored fields in immuno-oncology, a new temperature-resistant rabies and yellow fever vaccine,...

Pharma Technology Focus – Issue 60
GlobalData Healthcare

NeuPSIG 2017: personalized treatments may hold the key to treatment progress in neuropathic pain

NeuPSIG 2017: personalized treatments may hold the key to treatment progress in neuropathic pain
GlobalData Healthcare

NeuPSIG 2017: cell therapies may hold the key to opioid use in neuropathic pain

NeuPSIG 2017: cell therapies may hold the key to opioid use in neuropathic pain
GlobalData Healthcare

EULAR 2017: Big pharma dives back into the lupus pipeline

EULAR 2017: Big pharma dives back into the lupus pipeline
GlobalData Healthcare

EULAR 2017: Osteoarthritis pipeline product shows promise

EULAR 2017: Osteoarthritis pipeline product shows promise

Company Releases »

Application Case Study: Parallel Process Development and Scale-Up by Factor 300

SYSTAG, System Technik AG
Application Case Study: Parallel Process Development and Scale-Up by Factor 300

Dehumidified Air Ensures Quality Hormone Packaging for Orion Pharmaceuticals

Munters
Dehumidified Air Ensures Quality Hormone Packaging for Orion Pharmaceuticals

Testing Parenteral Products for Micro Leaks, Container Closure Integrity Test

PTI - Packaging Inspection Systems Testing Parenteral Products for Micro Leaks, Container Closure Integrity Test

Dry Powder Inhaler Monodose RS01

Plastiape Group Dry Powder Inhaler Monodose RS01

Pharmaceutical Insights »

Pharmaceutical Industry Reports »

Glioblastoma: could Zika virus offer new treatment options?

Glioblastoma: could Zika virus offer new treatment options?

China and infectious disease: the one to watch?

China and infectious disease: the one to watch?

Report: Chronic obstructive pulmonary disease market to reach $14.1bn by 2025

Report: Chronic obstructive pulmonary disease market to reach $14.1bn by 2025

Report: Venous thromboembolism market to grow at CAGR of 3.87%

Report: Venous thromboembolism market to grow at CAGR of 3.87%








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_-1100201212